Erratum: Amylin(1-8) is Devoid of Anabolic Activity in Bone (Calcif Tissue Int (2010) 86: (333) (DOI 10.1007/s00223-010-9338-3));Amylin(1-8) is devoid of anabolic activity in bone

Calcified Tissue International

Volumn 86, Issue 3, 2010, Pages 249-260

  Ellegaard, Maria ^a,b   Thorkildsen, Christian ^a   Petersen, Solveig ^b   Petersen, Jørgen Søberg ^a   Jørgensen, Niklas Rye ^b   Just, Rasmus ^a   Schwarz, Peter ^b   Ramirez, Maria Teresa ^a   Stahlhut, Martin ^a,c  

^a Zealand Pharma AS   (Denmark)

^b GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^c LEO PHARMA A S   (Denmark)

Author keywords

Amylin(1 8); Bone; Histomorphometry; Osteoblast; Ovariectomy

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; AMYLIN DERIVATIVE; AMYLIN [1-8]; CALCITONIN RECEPTOR; CALCITONIN RECEPTOR LIKE RECEPTOR; OSTEOCALCIN; OSTEOPROTEGERIN; PARATHYROID HORMONE RECEPTOR 1; PARATHYROID HORMONE[1-34]; RECEPTOR ACTIVITY MODIFYING PROTEIN 1; RECEPTOR ACTIVITY MODIFYING PROTEIN 2; RECEPTOR ACTIVITY MODIFYING PROTEIN 3; THY 1 ANTIGEN; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING SITE; BONE DENSITY; CELL PROLIFERATION; CELL STRAIN HEK293; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFICACY; DUAL ENERGY X RAY ABSORPTIOMETRY; EMBRYO; EXPERIMENTAL MODEL; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; MORPHOMETRICS; MOUSE; NEWBORN; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOPENIA; OVARIECTOMY; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN INTERACTION; TIBIA; TREATMENT DURATION;

EID: 77950865570     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00223-010-9342-7     Document Type: Erratum

References (25)

1. Alam AS, Moonga BS, Bevis PJ, Huang CL, Zaidi M (1993) Amylin inhibits bone resorption by a direct effect on the motility of rat osteoclasts. Exp Physiol 78:183-196
2. Christopoulos G, Perry KJ, Morfis M, Tilakaratne N, Gao Y, Fraser NJ, Main MJ, Foord SM, Sexton PM (1999) Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product. Mol Pharmacol 56:235-242
3. Cornish J, Callon KE, Cooper GJ, Reid IR (1995) Amylin stimulates osteoblast proliferation and increases mineralized bone volume in adult mice. Biochem Biophys Res Commun 207:133-139
4. Cornish J, Callon KE, Lin CQ, Xiao CL, Mulvey TB, Coy DH, Cooper GJ, Reid IR (1998) Dissociation of the effects of amylin on osteoblast proliferation and bone resorption. Am J Physiol Endocrinol Metab 274:E827-E833
5. Cornish J, Callon KE, King AR, Cooper GJ, Reid IR (1998) Systemic administration of amylin increases bone mass, linear growth, and adiposity in adult male mice. Am J Physiol Endocrinol Metab 275:E694-E699
6. Cornish J, Callon KE, Lin CQ, Xiao CL, Mulvey TB, Cooper GJ, Reid IR (1999) Trifluoroacetate, a contaminant in purified proteins, inhibits proliferation of osteoblasts and chondrocytes. Am J Physiol Endocrinol Metab 277:E779-E783
7. Cornish J, Callon KE, Lin CQ, Xiao CL, Gamble GD, Cooper GJ, Reid IR (1999) Comparison of the effects of calcitonin generelated peptide and amylin on osteoblasts. J Bone Miner Res 14:1302-1309
8. Cornish J, Callon KE, Gasser JA, Bava U, Gardiner EM, Coy DH, Cooper GJ, Reid IR (2000) Systemic administration of a novel octapeptide, amylin(1-8), increases bone volume in male mice. Am J Physiol Endocrinol Metab 279:E730-E735
9. Cornish J, Callon KE, Bava U, Kamona SA, Cooper GJ, Reid IR (2001) Effects of calcitonin, amylin, and calcitonin gene-related peptide on osteoclast development. Bone 29:162-168
10. Cornish J, Grey A, Callon KE, Naot D, Hill BL, Lin CQ, Balchin LM, Reid IR (2004) Shared pathways of osteoblast mitogenesis induced by amylin, adrenomedullin, and IGF-1. Biochem Biophys Res Commun 318:240-246
11. Dacquin R, Davey RA, Laplace C, Levasseur R, Morris HA, Goldring SR, Gebre-Medhin S, Galson DL, Zajac JD, Karsenty G (2004) Amylin inhibits bone resorption while the calcitonin receptor controls bone formation in vivo. J Cell Biol 164:509-514
12. Davey RA, Moore AJ, Chiu MW, Notini AJ, Morris HA, Zajac JD (2006) Effects of amylin deficiency on trabecular bone in young mice are sex-dependent. Calcif Tissue Int 78:398-403
13. Horcajada-Molteni MN, Davicco MJ, Lebecque P, Coxam V, Young AA, Barlet JP (2000) Amylin inhibits ovariectomyinduced bone loss in rats. J Endocrinol 165:663-668
14. Lee SK, Goldring SR, Lorenzo JA (1995) Expression of the calcitonin receptor in bone marrow cell cultures and in bone: a specific marker of the differentiated osteoclast that is regulated by calcitonin. Endocrinology 136:4572-4581
15. Muff R, Buhlmann N, Fischer JA, Born W (1999) An amylin receptor is revealed following co-transfection of a calcitonin receptor with receptor activity modifying proteins-1 or -3. Endocrinology 140:2924-2927
16. Nicholson GC, Moseley JM, Sexton PM, Mendelsohn FA, Martin TJ (1986) Abundant calcitonin receptors in isolated rat osteoclasts. Biochemical and autoradiographic characterization. J Clin Invest 78:355-360
17. Roh J, Chang CL, Bhalla A, Klein C, Hsu SY (2004) Intermedin is a calcitonin/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor/receptor activity-modifying protein receptor complexes. J Biol Chem 279:7264-7274
18. Romero DF, Bryer HP, Rucinski B, Isserow JA, Buchinsky FJ, Cvetkovic M, Liu CC, Epstein S (1995) Amylin increases bone volume but cannot ameliorate diabetic osteopenia. Calcif Tissue Int 56:54-61
19. Rossowski WJ, Jiang NY, Coy DH (1997) Adrenomedullin, amylin, calcitonin gene-related peptide and their fragments are potent inhibitors of gastric acid secretion in rats. Eur J Pharmacol 336:51-63
20. Udawela M, Christopoulos G, Tilakaratne N, Christopoulos A, Albiston A, Sexton PM (2006) Distinct receptor activity-modifying protein domains differentially modulate interaction with calcitonin receptors. Mol Pharmacol 69:1984-1989
21. Villa I, Rubinacci A, Ravasi F, Ferrara AF, Guidobono F (1997) Effects of amylin on human osteoblast-like cells. Peptides 18: 537-540
22. Villa I, Melzi R, Pagani F, Ravasi F, Rubinacci A, Guidobono F (2000) Effects of calcitonin gene-related peptide and amylin on human osteoblast-like cells proliferation. Eur J Pharmacol 409:273-278
23. Villa I, Dal Fiume C, Maestroni A, Rubinacci A, Ravasi F, Guidobono F (2003) Human osteoblast-like cell proliferation induced by calcitonin-related peptides involves PKC activity. Am J Physiol Endocrinol Metab 284:E627-E633
24. Wimalawansa SJ (1997) Amylin, calcitonin gene-related peptide, calcitonin, and adrenomedullin: a peptide superfamily. Crit Rev Neurobiol 11:167-239
25. Young A (2005) Amylin: physiology and pharmacoloy. Elsevier Academic Press, San Diego